AlphaRose Therapeutics Inc. — Form C (Regulation Crowdfunding)
AlphaRose Therapeutics Inc. of Austin, TX filed a Form C (Regulation Crowdfunding) with the SEC on 2025-01-29. Target raise $124K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-01-29
- Form: C
- Accession: 0001665160-25-000154
- Target amount: $124K
- Maximum amount: $1.2M
- Security type: Common Stock
- Securities offered: 91,851
- Price: $1.3500
- Deadline: 2025-04-30
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002051498
- Website: https://www.alpharose.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2023-10-31
- Address: 1401 Lavaca Street, #851, Austin, TX, 78701
- Employees: 1
Financials (as filed)
- Total assets (most recent): $682K
- Cash (most recent): $682K
- Net income (most recent): $-406K
- Short-term debt: $39K
- Long-term debt: $1.1M
People (5)
| Name | Role | Location |
|---|
| Masako Nakamura | Board Member | AUSTIN, TX |
| Casey Mcpherson | CEO, Principal Accounting and Financial Officer, and Board Member | AUSTIN, TX |
| Alan Edmund Walts | Board Member | AUSTIN, TX |
| Belinda Ann Termeer | Board Member | AUSTIN, TX |
| Lance Hirsch | Board Member | AUSTIN, TX |
Reg CF filing history (7)
More